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Abstract 
Ultrasonic irradiation of bromohydrins in the presence of (diacetoxyiodo)benzene and I2 generates alkoxyl 
radicals which lead in situ to intramolecular hydrogen abstraction on the C-19 non-activated carbon atoms in 
steroids producing tetrahydrofurans selectively in very good yields. Photolysis was less effective in promoting 
such conversions. ©1999 Elsevier Science Ltd. All rights reserved. 
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Remote functionalization of non-activated carbon atoms has found particular elevance in steroid 
chemistry.l As part of our studies dealing with the synthesis of potential aromatase inhibitors, namely 
19-hydroxyandrostane derivatives, 2 to be employed therapeutically onestrogen-dependent diseases, we 
focused our attention on oxidative cyclization at C-19. Functionalization of this angular methyl group 
is commonly achieved through the preparation of tetrahydrofurans as precursors of 19-hydroxysteroids 1 
and, consequently, the generation of alkoxyl radicals uitably positioned to allow intramolecular hydro- 
gen abstraction is required (Scheme 1). 
Scheme 1. 
Most of the methods that have been developed to achieve this remote oxidation involve the addition 
of hypohalous acids to A 5-steroids 1 to introduce the hydroxyl group at C-6 (Scheme 2). Subsequent 
oxidation of the halohydrins 2 at C-19 take place through the formation of the corresponding 613- 
alkoxyl radicals that allows intramolecular hydrogen abstraction at C-19 leading to the cyclic-ethers 
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3. To generate alkoxyl radicals from alcohols, photolytic decomposition of heavy metals derivatives and 
iodine have been traditionally employed. 1,3 
AcO ~ 
1 




More recently, in situ photolysis of alcohols with visible light in the presence of (diacetoxy- 
iodo)benzene (DIB) and iodine was reported as a higher yielding methodology. 4 However, when 1,2- 
bromohydrins were submitted in a first trial of this reaction (with DIB/I2) under the conditions reported 
for alcohols, the corresponding 613,19-tetrahydrofurans were obtained in very low yields. Such results 
led us to use sonolysis as an alternative to photolysis. Indeed, acoustic avitation generated within a 
liquid phase by power ultrasound (20 to 100 KHz) has been successfully used to promote chemical 
reactivity and the synthetic applications of this activation process cover a wide range of chemical 
transformations. 5 Nevertheless, onochemical oxidation of C-H bonds, especially non-activated ones, 
has not been extensively reported. The creation of a new C-O bond with LTA/I2 under sonochemical 
conditions was the single example we found in the literature. 6 
Our group has been performing research in this field of growing interest, directed towards the study 
of homogenous and heterogeneous systems. 7 In a previous communication we reported the preliminary 
results obtained when ultrasonic irradiation was applied to improve the preparation of tetrahydrofurans 
through the hypoiodite reaction, using the DIB/I2 system. 7a The study we present here was performed 
while seeking to optimize the sonolyses of bromohydrins in the presence of DIB/I2 towards formation 
of 613,19-tetrahydrofurans in itu. The evaluation of some important reaction parameters, uch as 
temperature, reaction time and molar ratio of DIB/I2 per mol of substrate and their effects on the 
conversion rates and on the formation of by-products, has been undertaken. 
Substrates 4-6 (Scheme 3) have been previously synthesized by reaction of the corresponding com- 
mercially available AS-steroids with 10% HC104 and N-bromosuccinimide 8 and fully characterized by 
1H and 13C NMR. 9 The 20-oxopregn-5-ene-313,21-di-yl diacetate required to prepare the bromohydrin 
7, may be easily obtained from the also commercially available 20-oxopregn-5-ene-313-yl acetate, as 
previously described by us. l0 
AcO ~'R '  
Br 
• " ~  RI 
AcO 
Br 
4 .................... R; R': = O .................... 8
5 ............... R: C8H17; R': H ................. 9 
6 .............. R: COCH3; R': H ............... 10 
7 ........... R: COCH2OAc; R': H ............. 11 
Scheme 3.
As a first approach we carded out a set of experiments on substrate 4 at various temperatures (35, 40, 
45 and 50°C), using an ultrasonic leaning bath (35 KHz) with circulating water. The best result was 
observed at the selected temperature of 45°C. This implies that the cavitation efficiency is higher under 
these reaction conditions, consequently allowing an improvement in the chemical reactivity. Further 
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Table 1 
Reaction of bromohydrins with DIB/I2 
Entry Substrate a) DIB I 12 Irradiat ion b) Product (%)c) 
I 4 1.1 / 1.0 light 8 (43) 
II 4 1.4 / 1.2 light 8 (77) 
III 4 1.I / 1.0 ))) 8 (86) 
IV 4 1.4 / 1.2 ))) 8 (92) 
V 5 1.4 / 1.2 ))) 9 (90) 
VI 6 1.4/ 1.2 ))) 10 (90) 
VII 7 1.4/ 1.2 ))) 11 (99) 
a) substrate: 0.10 - 0.12 mmol; solvent mixture: cyclohexane/benzene (10: !); reaction temperature: 45"C. 
b) Light: 200W (2 lamps of 100W tungsten filaments); ))): ultrasonic bath Bandelin Sonorex Super RK 510H, 
225-450 W, 35 KHz; reaction time: 50 minutes. ©) Quantified and identified by IH nmr (isolated crude preduct) 
increase of the temperature l d to a larger consumption of substrate 4, however a higher amount of 
by-products, namely the corresponding 513,613-epoxide was produced, while the target product 8 was 
obtained in a lower yield. Furthermore, 50 min was established as a suitable reaction time to accomplish 
this conversion under sonochemical conditions. In fact, we have performed the experiments using 
0.10-0.12 mmol of substrate and complete conversions were found after that irradiation time. The use of 
extended ultrasonic periods gave an intractable mixture of products. 
By changing the molar ratio of DIB/I2 per mol of substrate to 1.4/1.2 an additional optimization was 
attained. Interestingly, at this stoichiometry the conversion rate enhancement achieved for photolytic 
reactions (Table 1, Entries I and II), was found to be considerably higher than that of the reaction 
performed under ultrasonic onditions (Table 1, Entries III and IV). 
The combination of all optimized parameters led to a synergic effect on the sonochemical remote 
oxidation on C-19 for substrate 4 (Table 1, Entry IV). With the aim of illustrating the versatility and 
synthetic potential of this ultrasonic approach for the hypoiodite reaction performed with DIB/I2, these 
studies were extended to the analogous derivatives of cholestane 5 and of 20-oxo- and 21-acetoxy- 
20-oxopregnanes 6 and 7, which have not been investigated before under such reaction conditions. 
As depicted in Table 1 (Entries V-VII) the corresponding 6[3,19-tetrahydrofuranic steroids 9-11 were 
readily accessible by the same sonolytic procedure. The reactions proceeded smoothly under the mild 
conditions used. It should also be emphasized that a 40-fold scale-up of a sonicated reaction conducted for 
substrate 4 was successful (70% yield, after crystallization). All the compounds were fully characterized 
by 1H and 13C NMR. ll In closing, this study has demonstrated that ultrasonic irradiation is a valuable 
alternative to light since it provides better yields, easier work-up of the products and good selectivity. 
The results attained are in agreement with the proposition that radical processes are favoured by 
sonication. The easy availability of ultrasonic leaning baths as well as its operational simplicity render 
this procedure xtremely attractive and practical. Besides, the application to the synthesis of potential 
precursors of highly valuable 19-hydroxyandrostane derivatives as well as cholestane and pregnane 
analogues, allow us to believe that this methodology will find general acceptance in organic synthesis. 
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